Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 26, 2020; 8(18): 4075-4093
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.4075
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.4075
Variable | Patients (n = 109) |
Mean age (yr) | 25.52 |
Sex (male) | 46 (42.59%) |
Race | 10 (6.78%) |
White | 7 (70%) |
Black | 3 (30%) |
IBD | 48 (44.44%) |
CD | 13 (27.65%) |
UC | 32 (68.08%) |
Non-specific | 3 (6.38%) |
PSC | |
Small Ducts | 4 (3.70%) |
AIH (median) | |
SAH pre-treatment (pts) | 17 (13-22) |
SAH post-treatment (pts) | 19 (13-25) |
Clinical presentation | |
Fever | 7 (6.48%) |
Dyspnea | 1 (0.93%) |
Headache | 1 (0.93%) |
Jaundice | 31 (28.70%) |
Pruritus | 11 (10.19%) |
Urine alteration | 6 (5.55%) |
Choluria | 5 (83.33%) |
Hematuria | 1 (16.66%) |
Nausea | 4 (3.70%) |
Emesis | 8 (7.40%) |
Without blood | 4 (50%) |
Hematemesis | 4 (50%) |
Diarrhea | 11 (10.19%) |
Stools | 18 (16.66%) |
Hematochezia | 1 (5.55%) |
Melena | 1 (5.55%) |
Incontinence | 1 (5.55%) |
Acholia | 3 (16.66%) |
Watery stools | 11 (61.11%) |
Steatorrhea | 1 (5.55%) |
Abdominal pain | 21 (19.44%) |
Joint pain | 2 (1.85%) |
Weight loss | 9 (8.33%) |
Fatigue | 22 (20.37%) |
Family history | 4 (3.70%) |
Hepatomegaly | 15 (13.89%) |
Splenomegaly | 12 (11.11%) |
Ascites | 7 (6.48%) |
Fecal occult blood | 3 (2.78%) |
Cirrhosis | 17 (15.74%) |
Encephalopathy | 2 (1.85%) |
Comorbidities | |
Esophageal varices | 13 (12.03%) |
Hypothyroidism | 1 (0.93%) |
Anemia | 1 (0.93%) |
Alcohol-induced pancreatitis | 1 (0.93%) |
Hepatic insufficiency | 1 (0.93%) |
Rheumatoid arthritis | 1 (0.93%) |
Smoker | 1 (0.93%) |
Membranous glomerulonephritis | 1 (0.93%) |
Hepatocarcinoma | 1 (0.93%) |
Pyoderma gangrenosum | 1 (0.93%) |
Reflux nephropathy | 1 (0.93%) |
Post-infantile giant cell hepatitis | 4 (3.70%) |
Renal cell carcinoma | 1 (0.93%) |
Autoimmune thyroiditis | 1 (0.93%) |
Biopsy | 109 (100%) |
Grade (Batts-Ludwig) | 29 (26.85%) |
None | 2 (6.89%) |
Minimal | 1 (3.44%) |
Mild | 10 (34.48%) |
Moderate | 11 (37.93%) |
Severe | 5 (17.24%) |
Stage (Batts-Ludwig) | 37 (34.25%) |
None | 1 (2.70%) |
Portal fibrosis | 14 (37.83%) |
Periportal fibrosis | 10 (27.02%) |
Septal fibrosis | 9 (24.32%) |
Cirrhosis | 3 (8.10%) |
Laboratory tests (mean) | |
Hb (g/dL) | 10.20 |
Ht (%) | 32.8 |
Leucocytes (mm3) (median) | 7600 |
Platelets (mm3) (median) | 185000 |
Prothrombin time (s) | 15.35 |
INR | 1.41 |
ALT (U/L) | 378.2 |
AST (U/L) | 378.2 |
GGT (U/L) | 316.6 |
ALP (U/L) | 693.4 |
Total bilirubin (mg/dL) | 5.14 |
Direct bilirubin (mg/dL) | 4.43 |
Total protein (g/dL) | 17.82 |
Albumin (g/dL) (median) | 3.09 |
Total globulins (mg/L) | 51410 |
IgG total (mg/dL) | 2762 |
IgA total (mg/dL) | 230.3 |
IgM total (mg/dL) | 729.7 |
Antibodies | |
LKM1 | 3 (2.78%) |
AMA | 3 (2.78%) |
ANA | 59 (54.63%) |
SMA | 33 (30.56%) |
pANCA | 36 (33.33%) |
HLA | 18 (16.66%) |
Medications | 63 (58.33%) |
Steroids | 62 (98.41%) |
Azathioprine | 48 (76.19%) |
6-mercaptopurine | 1 (1.58%) |
Ursodeoxycholic acid | 47 (74.60%) |
Mesalazine | 7 (11.11%) |
Antibiotics | 3 (4.76%) |
D-penicillamine | 1 (1.58%) |
Cyclosporine A | 1 (1.58%) |
Mycophenolate mofetil | 2 (3.17%) |
Clinical improvement | 61 (56.48%) |
Relapse | 41 (37.96%) |
Transplantation | 13 (12.87%) |
Mean time from diagnosis-transplant (mo), n = 10 (76.92%) | 74.90 |
Transplant medications, n = 4 | 4 (30.76%) |
Steroids | 4 (100%) |
Basiliximab | 1 (25%) |
Cyclosporine | 2 (50%) |
Azathioprine | 1 (25%) |
Tacrolimus | 2 (50%) |
Mycophenolate mofetil | 2 (50%) |
Mean time follow-up (mo) | 59.18 |
Death | 4 (3.70%) |
Ref. | Country | Sex | Age | Clinical presentation | IBD | Co-morbidities | Antibodies | HLA | Treatment | Relapse | Outcome | Miscellaneous |
Wurbs et al[3], 1995 | Germany | F | 28 | Fever, Choluria, Weight Loss, Fatigue | N | None | pANCA, SMA | DR | Steroids, AZA | N | Recovery | |
Lawrence et al[4], 1994 | United States | M | 39 | Nausea, Emesis, Fatigue, Hepatomegaly, Occult stool blood | UC | Cirrhosis | SMA | NA | Steroids, AZA, Cyclosporine A | N | Recovery | |
Nalepa et al[5], 2017 | Poland | M | 10 | Jaundice, Diarrhea, Abdominal Pain, Hepatomegaly, Splenomegaly, Ascites, Hematemesis | UC | Cirrhosis, Esophageal Varices | ANA, SMA | NA | Steroids, AZA, UDCA, MSM | Y | Recovery | Liver transplantation |
Luketic et al[6], 1997 | United States | F | 38 | Jaundice, Nausea, Fatigue, Ascites, Hematemesis | N | None | ANA | NA | Steroids, AZA | Y | Recovery | Liver transplantation |
Mueller et al[7], 2018 | Germany | F | 15 | Vomiting, Fatigue | N | None | ANA, pANCA, SMA, AMA | NA | Steroids, UDCA | N | Recovery | |
Guerrero-Hernández et al[8], 2007 | Mexico | F | 22 | Jaundice, Choluria, Fatigue | N | None | ANA, pANCA | NA | Steroids, AZA, UDCA | N | Recovery | |
Takiguchi et al[9], 2002 | Japan | F | 36 | Fever | N | None | ANA, pANCA | A24, A31, B35, B61, Cw4, DR4 | Steroids, AZA, UDCA | Y | Recovery | |
McNair et al[10], 1998 | United Kingdom | M | 38 | Jaundice, Watery Stools, Abdominal Pain, Weight Loss | UC | Encephalopathy | ANA, LKM1, pANCA, SMA | B8, DR3 | Steroids, AZA | Y | Death | |
McNair et al[10], 1998 | United Kingdom | F | 20 | Jaundice, Itching | N | None | ANA, pANCA, SMA | ND | Steroids, AZA, UDCA | Y | Recovery | |
McNair et al[10], 1998 | United Kingdom | M | 26 | Dyspnea, Jaundice | N | None | ANA, pANCA | A1, B8, DR3 | Steroids, AZA | Y | Recovery | |
McNair et al[10], 1998 | United Kingdom | M | 14 | Jaundice, Diarrhea, Abdominal Pain | UC | None | ANA, pANCA, SMA | A1, B8, DR3 | Steroids, AZA | Y | Recovery | |
McNair et al[10], 1998 | United Kingdom | M | 18 | Jaundice, Diarrhea, Abdominal Pain, Weight Loss | N | None | pANCA, SMA | ND | Steroids, AZA, UDCA | N | Recovery | |
Man et al[11], 2017 | Romania | M | 13 | Jaundice, Hepatomegaly, Splenomegaly | N | Esophageal Varices | SMA | NA | Steroids, AZA, UDCA, Mycophenolate Mofetil | Y | Recovery | |
Malik et al[12], 2010 | United States | F | 22 | Diarrhea, Abdominal Pain | CD | None | NA | NA | Steroids, AZA, UDCA, Mycophenolate Mofetil | Y | Recovery | |
Lamia et al[13], 2012 | Tunisia | M | 4 | Hematuria, Diarrhea, Hepatomegaly, Splenomegaly | NSIC | None | ANA, pANCA, SMA | NA | Steroids, AZA, UDCA, 6-MP | Y | Recovery | |
Lee et al[14], 2005 | Malaysia | F | 5 | Jaundice, Itching, Steatorrhea | N | None | ANA, SMA | NA | Steroids, UDCA | N | Recovery | |
Santos et al[15], 2012 | Colombia | M | 36 | Jaundice, Hematemesis, Abdominal Pain, Hepatomegaly, Ascites | N | Cirrhosis, Encephalopathy, Esophageal Varices | ANA | NA | Steroids, AZA, UDCA | Y | Recovery | Liver transplantation |
Santos et al[15], 2012 | Colombia | F | 35 | Headache, Jaundice, Fatigue | UC | Esophageal Varices | ANA, pANCA, SMA | NA | Steroids, UDCA, MSM | Y | Recovery | |
Santos et al[15], 2012 | Colombia | F | 45 | Jaundice, Choluria, Acholia, Hepatomegaly | NSIC | Hypothyroidism | ANA, SMA | NA | Steroids, AZA, UDCA | N | Recovery | |
Saltik-Temizel et al[16], 2004 | Turkey | M | 11 | Jaundice, Itching, Abdominal Pain, Hepatomegaly, Splenomegaly, Fecal Occult Blood | UC | None | pANCA, SMA | NA | Steroids, AZA, UDCA, MSM | Y | Recovery | |
Gopal et al[17], 1999; Nagral et al[18], 1999 | India | F | 14 | Jaundice, Hepatomegaly, Splenomegaly, Ascites | N | Cirrhosis, Esophageal Varices | ANA | NA | Steroids, D-penicillamine | Y | Recovery | Liver transplantation |
Lüth et al[19], 2009 | Germany | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Farid et al[20], 2015 | Bahrain | F | 11 | Jaundice, Nausea, Vomit, Abdominal Pain | UC | Cirrhosis | NA | NA | Steroids, AZA | Y | Death | Liver transplantation |
Floreani et al[21], 2005 | Italy | F | 26 | NA | NA | NA | NA | NA | NA | NA | NA | |
Floreani et al[21], 2005 | Italy | M | 19 | NA | NA | NA | NA | NA | NA | NA | NA | |
Floreani et al[21], 2005 | Italy | M | 32 | NA | NA | NA | NA | NA | NA | NA | NA | |
Floreani et al[21], 2005 | Italy | M | 27 | NA | NA | NA | NA | NA | NA | NA | NA | |
Floreani et al[21], 2005 | Italy | F | 15 | NA | NA | NA | NA | NA | NA | NA | NA | Liver transplantation |
Floreani et al[21], 2005 | Italy | F | 15 | NA | NA | NA | NA | NA | NA | NA | NA | |
Floreani et al[21], 2005 | Italy | F | 16 | NA | NA | NA | NA | NA | NA | NA | NA | |
Gohlke et al[22], 1996; Zenouzi et al[23], 2014 | Germany | M | 19 | NA | N | Esophageal Varices | ANA, pANCA, SMA | A1, A32, B8, Cw3, Cw7, DR3, DR4 | Steroids, AZA, UDCA | Y | Recovery | |
Gohlke et al[22], 1996; Zenouzi et al[23], 2014 | Germany | M | 28 | NA | UC | Esophageal Varices | ANA, pANCA | A1, A32, B7, B8, Cw7, DR3, DR4, DR52, DR53, DQ2, DQ3 | Steroids, AZA, UDCA | Y | Recovery | |
Gohlke et al[22], 1996; Zenouzi et al[23], 2014 | Germany | M | 18 | NA | N | Cirrhosis, Esophageal Varices | ANA, pANCA, SMA | A1, A25, B8, DR3 | Steroids, AZA, UDCA | Y | Recovery | Liver transplantation |
Abdo et al[24], 2002 | Canada | M | 15 | Jaundice, Fatigue | UC | None | ANA, SMA | NA | Steroids, AZA | Y | Recovery | |
Abdo et al[24], 2002 | Canada | M | 51 | Abdominal Pain, Weight Loss, Fatigue | N | None | ANA, SMA | NA | Steroids, AZA, UDCA | Y | Recovery | |
Abdo et al[24], 2002 | Canada | M | 54 | Abdominal Pain, Fatigue, Splenomegaly | UC | Cirrhosis, Alcohol-induced Pancreatitis | NA | NA | Steroids, AZA, UDCA, MSM | Y | Recovery | |
Abdo et al[24], 2002 | Canada | F | 25 | Jaundice, Itching, Abdominal Pain, Fatigue, Hepatomegaly | N | None | ANA, SMA | NA | Steroids, AZA, UDCA | Y | Recovery | |
Abdo et al[24], 2002 | Canada | F | 23 | Fatigue | UC | None | ANA, SMA | NA | Steroids, AZA, UDCA, MSM | Y | Recovery | |
Abdo et al[24], 2002 | Canada | M | 20 | Jaundice, Abdominal Pain, Weight Loss, Hepatomegaly, Splenomegaly | N | Cirrhosis | ANA, SMA | NA | Steroids, AZA, UDCA | Y | Recovery | Liver transplantation |
van Buuren et al[25], 2000 | Netherlands | M | 7 | NA | UC | None | ANA, SMA | NA | Steroids, AZA | NA | Recovery | |
van Buuren et al[25], 2000 | Netherlands | M | 14 | NA | CD | None | ANA, SMA | NA | Steroids, AZA | NA | Recovery | |
van Buuren et al[25], 2000 | Netherlands | F | 21 | NA | UC | None | ANA, pANCA | NA | Steroids, AZA | NA | Recovery | |
van Buuren et al[25], 2000 | Netherlands | F | 22 | NA | CD | None | ANA, SMA | NA | Steroids, AZA | Y | Recovery | Liver transplantation |
van Buuren et al[25], 2000 | Netherlands | M | 20 | NA | UC | None | SMA | NA | Steroids, AZA, UDCA | NA | Recovery | |
van Buuren et al[25], 2000 | Netherlands | M | 23 | NA | UC | Cirrhosis, Esophageal Varices | ANA, pANCA | NA | Steroids, AZA, UDCA | NA | Recovery | |
van Buuren et al[25], 2000 | Netherlands | M | 37 | NA | N | None | ANA | NA | Steroids, AZA, UDCA | NA | Recovery | |
van Buuren et al[25], 2000 | Netherlands | M | 54 | NA | CD | None | ANA, SMA | NA | Steroids, AZA, UDCA | Y | Recovery | Liver transplantation |
van Buuren et al[25], 2000 | Netherlands | F | 44 | Jaundice | UC | Hepatic Insufficiency | pANCA | NA | Steroids, AZA, UDCA | Y | Recovery | Liver transplantation |
Li et al[26], 2017 | China | M | 52 | Jaundice, Itching | N | Rheumatoid Arthritis | NA | NA | Steroids | N | Recovery | |
Gharibpoor et al[27], 2017 | Iran | M | 26 | Jaundice, Itching, Choluria, Acholia, Abdominal Pain, Weight Loss, Hepatomegaly | N | None | ANA, SMA | NA | Steroids, AZA, UDCA | N | Recovery | |
Sander et al[28], 2007 | Germany | M | 24 | CD | None | ANA, SMA | B8, DR4 | Steroids, AZA, UDCA | Y | Recovery | ||
Smolka et al[29], 2016 | Czech Republic | M | 16 | Jaundice | N | None | ANA, pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | M | 17 | Diarrhea, Abdominal Pain | UC | None | pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | F | 15 | Fatigue | N | None | pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | M | 14 | UC | None | NA, pANCA, SMA | NA | NA | NA | NA | ||
Smolka et al[29], 2016 | Czech Republic | F | 16 | CD | None | pANCA | NA | NA | NA | NA | ||
Smolka et al[29], 2016 | Czech Republic | F | 10 | Fever, Weight Loss, Fatigue | NSIC | None | LKM1, pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | M | 12 | Abdominal Pain | UC | None | pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | F | 9 | Melena, Fatigue | UC | None | ANA, pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | M | 3 | Diarrhea, Abdominal Pain | UC | None | ANA, pANCA | NA | NA | NA | NA | |
Smolka et al[29], 2016 | Czech Republic | F | 9 | N | None | ANA, pANCA, SMA | NA | NA | NA | NA | ||
Smolka et al[29], 2016 | Czech Republic | F | 15 | Itching, Diarrhea, Abdominal Pain | CD | None | ANA, pANCA | NA | NA | NA | NA | |
Griga et al[30], 2000 | United Kingdom | F | 24 | Diarrhea | CD | None | ANA, pANCA | NA | Steroids, MSM, UDCA | N | Recovery | |
Griga et al[30], 2000 | United Kingdom | M | 28 | Jaundice, Itching | N | None | ANA, pANCA | B8, DR4 | Steroids, UDCA | N | Recovery | |
Warling et al[31], 2014 | Belgium | M | 29 | Jaundice, Fatigue | UC | Membranous Glomerulonephritis | pANCA | DR3 | Steroids, AZA, UDCA, MSM, 6-MP | Y | Recovery | |
Hyslop et al[32], 2010 | United States | NA | 40 | NA | UC | None | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 24 | NA | UC | None | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 53 | NA | CD | Cirrhosis | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 37 | NA | UC | None | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 32 | NA | UC | Cirrhosis | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 61 | NA | CD | Cirrhosis | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 52 | NA | CD | None | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 26 | NA | CD | Cirrhosis | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 33 | NA | UC | None | ANA | NA | NA | NA | NA | |
Hyslop et al[32], 2010 | United States | NA | 44 | NA | UC | Cirrhosis | ANA | NA | NA | NA | NA | |
Fukuda et al[33], 2012 | Japan | M | 72 | Ascites | N | Cirrhosis, Hepatocellular Carcinoma | ANA, AMA | DRB1*0405, DRB1*0901 | Steroids, UDCA | Y | Death | |
Hatzis et al[34], 2001 | Greece | F | 46 | Fever, Arthralgia, Fatigue, Splenomegaly | N | Nephrectomy for Reflux Nephropathy | ANA, pANCA, SMA | A3, A11, B16, B35, Cw4, DR13, DR14, DR52, DQ6 | Steroids, AZA, UDCA, Antibiotics | N | Recovery | |
Thakker et al[35], 2010 | India | F | 9 | Fever, Jaundice, Itching, Arthralgia, Fatigue, Hepatomegaly, Splenomegaly | N | None | ANA | NA | Steroids, UDCA | N | Recovery | |
Koskinas et al[36], 1999 | Greece | M | 18 | Fever, Jaundice, Hematochezia, Fatigue, Hepatomegaly, Splenomegaly, Ascites | UC | Pyoderma Gangrenosum | NA | A2, A32, B7, B21, B49, Bw4, Bw6, DR6, DR10, DR13 | Steroids, AZA, UDCA, MSM, Antibiotics | Y | Recovery | |
Lucas et al[37], 2007 | United States | M | 18 | Fecal incontinence, Abdominal Pain | UC | NA | NA | NA | NA | NA | NA | |
Protzer et al[38], 1996 | Switzerland | M | 22 | Jaundice, Nausea, Diarrhea, Abdominal Pain, Fatigue | UC | PIGCH | SMA | A1, A2, B8, B44, Cw5, Cw7, DR3, DR52, DQ2 | Steroids, UDCA | Y | Recovery | |
Protzer et al[38], 1996 | Switzerland | F | 32 | N | PIGCH | pANCA | A2, A28, B55, B67, Cw3, DR4, DR11, DQ2, DQ3 | Steroids, AZA | Y | Recovery | ||
Protzer et al[38], 1996 | Switzerland | M | 28 | N | Cirrhosis, PIGCH | ANA | A1, B8, DR3 | Steroids, AZA | Y | Death | ||
Protzer et al[38], 1996 | Switzerland | M | 26 | N | PIGCH | ANA | A1, B8, DR3 | Steroids, UDCA | Y | Recovery | ||
Hong-Curtis et al[39], 2004 | United States | F | 34 | Jaundice, Itching, Fatigue | UC | Anemia | ANA | NA | Steroids, UDCA, Antibiotics | Y | Recovery | |
Simão et al[40], 2012 | Portugal | M | 15 | Itching | N | None | ANA, AMA | NA | Steroids, AZA, UDCA | Y | Recovery | |
Larsen et al[41], 2012 | Denmark | M | 10 | Vomiting, Diarrhea, Abdominal Pain, Weight Loss | CD | None | pANCA, SMA | NA | Steroids, AZA, UDCA | N | Recovery | |
Guerra et al[42], 2016 | Peru | F | 22 | Jaundice, Choluria, Fatigue, Splenomegaly, Ascites | N | Cirrhosis, Esophageal Varices | ANA | A2, A11, B35, B60, DR9, DR13 | Steroids, UDCA | Y | Recovery | Liver transplantation |
Ng et al[43], 2011 | Australia | F | 33 | NA | NA | NA | NA | NA | UDCA | NA | NA | |
Igarashi et al[44], 2017 | Japan | F | 19 | N | None | ANA | NA | Steroids, UDCA | Y | Recovery | ||
Igarashi et al[44], 2017 | Japan | M | 61 | N | Renal Cell Carcinoma | NA | NA | Steroids, UDCA | Y | Recovery | ||
Gargouri et al[45], 2013 | Tunisia | M | 10 | Jaundice, Abdominal Pain, Fatigue, Hepatomegaly, Splenomegaly | N | Esophageal Varices | pANCA | NA | Steroids, AZA, UDCA | N | Recovery | |
Patrico et al[46], 2013 | Italy | F | 7 | Fever, Acholia, Hepatomegaly | N | None | LKM1 | NA | Steroids, AZ | Y | Recovery |
- Citation: Ballotin VR, Bigarella LG, Riva F, Onzi G, Balbinot RA, Balbinot SS, Soldera J. Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: A case report and systematic review. World J Clin Cases 2020; 8(18): 4075-4093
- URL: https://www.wjgnet.com/2307-8960/full/v8/i18/4075.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i18.4075